Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$150,000.00
Aug 1, 2022
For-profit organization
Enabling remote visual intelligence and guided assistance for support teams
995221
ICwhatUC will validate and develop functionality that will enable customer support teams to complete their work with additional remote visual context, AI guidance, and task/process automation.
$100,000.00
Aug 1, 2022
For-profit organization
Development of wheelchair power assist for caregivers
995261
Companion power assist for caregivers is designed to be used indoors and outdoors in conjunction with a wide variety of manual wheelchairs. Operated by an attendant only, it can be used by a range of clients, where the ability to self-propel in a manual wheelchair is not possible.
$12,898.00
Aug 1, 2022
For-profit organization
IP Assist - Intellectual Property Strategy Engagement - Level 2
995265
The Project will support development of intellectual property capacity within the Firm
$500,000.00
Aug 1, 2022
For-profit organization
Development and set-up of processes for training in studio-grade virtual production capabilities.
995337
Project will be supporting the development of the software and processes used in virtual production sufficient for both training and production volume. The project will include training, research development and early commercial applications.
$294,006.00
Aug 1, 2022
For-profit organization
Development of meltblown material used of oil absorption and environmentally sensible formulations
995507
Development of Meltblown fabric for Oil absorption application
$2,100.00
Aug 1, 2022
For-profit organization
IP Assist: Intellectual Property Strategy Engagement
995656
The Project will support development of intellectual property capacity within the Firm.
$400,000.00
Aug 1, 2022
For-profit organization
BI - Enterprise Sales Playbook
995694
The firm will develop an Enterprise Sales Playbook.
$75,000.00
Aug 1, 2022
For-profit organization
ARP - Productization of Recommendation Engine
995711
Refinement of the Recommendation Engine for public release.
$362,000.00
Aug 1, 2022
For-profit organization
UpMeals software platform – Phase 2
995757
Develop an advanced software system for healthy meal ordering and delivery processes including: generating, producing, labeling and distributing customized meal products.
$327,103.00
Aug 1, 2022
Academia
Clinical CAR-T cell raman spectroscopy analysis
996027
The approval of chimeric antigen receptor T-cell (CAR-T) therapies has been a major breakthrough for patients with relapsed or refractory blood cancers. However, CAR-T cells are highly complex, live cell therapies, and it has proven difficult to predict CAR-T cell potency. Great improvements in laser and detector technologies have led to an explosive growth in biomedical applications of Raman spectroscopy (RS), including leading contributions by this group. RS measures the macromolecular changes in T cells that are phenotypical of their activation state and other changes. The objective of this project is to contribute to the NRC search for potency biomarkers, based on the RS analysis of CLIC-01 patient cell samples taken prior to infusion. This contributes a novel and orthogonal analytical dimension to the overall NRC search for biomarkers that predict the efficacy of the treatment for each patient, and thereby when costly CAR-T cell treatments should be performed